The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function

Inhibitors of VEGF receptor (VEGFR) signaling such as sorafenib and sunitinib that are currently used in the treatment of malignant diseases have been shown to affect immunological responses by inhibition of the function of antigen presenting cells and T lymphocytes. The VEGFR-inhibitor axitinib has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Heine, Annkristin, Held, Stefanie Andrea Erika, Daecke, Solveig Nora, Riethausen, Kati, Kotthoff, Philipp, Flores, Chrystel, Kurts, Christian, Brossart, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4456373/
https://ncbi.nlm.nih.gov/pubmed/26042424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0128897
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados